PT89109A - Metodo para melhorar a funcao cognitiva por administracao de d-ciclosserina e suas pro-drogas - Google Patents
Metodo para melhorar a funcao cognitiva por administracao de d-ciclosserina e suas pro-drogasInfo
- Publication number
- PT89109A PT89109A PT89109A PT8910988A PT89109A PT 89109 A PT89109 A PT 89109A PT 89109 A PT89109 A PT 89109A PT 8910988 A PT8910988 A PT 8910988A PT 89109 A PT89109 A PT 89109A
- Authority
- PT
- Portugal
- Prior art keywords
- cycloserine
- pro
- drugs
- administration
- improving
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/127,121 US4904681A (en) | 1987-12-01 | 1987-12-01 | D-cycloserine and its prodrugs as cognitive enhancers |
Publications (2)
Publication Number | Publication Date |
---|---|
PT89109A true PT89109A (pt) | 1989-12-29 |
PT89109B PT89109B (pt) | 1993-07-30 |
Family
ID=22428413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT89109A PT89109B (pt) | 1987-12-01 | 1988-11-29 | Metodo para melhorar a funcao cognitiva por administracao de d-ciclosserina e suas pro-drogas |
Country Status (20)
Country | Link |
---|---|
US (1) | US4904681A (pt) |
EP (2) | EP0319824B1 (pt) |
JP (2) | JPH0621065B2 (pt) |
KR (1) | KR0134198B1 (pt) |
AT (1) | ATE68698T1 (pt) |
AU (4) | AU622630B2 (pt) |
CA (1) | CA1328617C (pt) |
DE (1) | DE3865817D1 (pt) |
DK (1) | DK173589B1 (pt) |
ES (1) | ES2040314T3 (pt) |
FI (1) | FI885559A0 (pt) |
GR (1) | GR3003571T3 (pt) |
IE (1) | IE61825B1 (pt) |
IL (1) | IL88531A (pt) |
NO (1) | NO885337D0 (pt) |
NZ (1) | NZ227131A (pt) |
PH (1) | PH26467A (pt) |
PT (1) | PT89109B (pt) |
WO (1) | WO1989005144A1 (pt) |
ZA (1) | ZA888981B (pt) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5187171A (en) * | 1989-01-09 | 1993-02-16 | G. D. Searle & Co. | Use of a glycine b partial agonist as an antipsychotic |
US5061721A (en) * | 1989-03-15 | 1991-10-29 | G. D. Searle & Co. | Composition containing d-cycloserine and d-alanine for memory and learning enhancement or treatment of a cognitive or psychotic disorder |
US5260324A (en) * | 1990-02-06 | 1993-11-09 | G. D. Searle & Company | Composition containing D-cycloserine and D-alanine for memory and learning enhancement or treatment of a cognitive or psychotic disorder |
US5066665A (en) * | 1990-05-21 | 1991-11-19 | Warner-Lambert Co. | Substituted isoxazolidin-3-ones and derivatives thereof acting at muscarinic receptors |
JPH07505908A (ja) * | 1992-09-28 | 1995-06-29 | マックセチーニ、マリア ルイザ | Nmda受容体のアロステリックモジュレーター |
US5428069A (en) * | 1993-01-11 | 1995-06-27 | The United States Of America As Represented By The Department Of Health & Human Services | Treating cognition with, aminocyclopropanecarboxylic derivatives |
US5523323A (en) * | 1993-09-14 | 1996-06-04 | Maccecchini; Maria-Luisa | Use of partial agonists of the NMDA receptor to reduce opiate induced tolerance and dependence |
NZ260302A (en) * | 1994-04-13 | 1996-05-28 | New Zealand Meat Ind Res Inst | Treating bait aversion by including substances which disrupt the associative learning process into bait compositions |
WO1996015787A1 (en) * | 1994-11-23 | 1996-05-30 | G.D. Searle & Co. | Use of amino-isoxazolidone compounds for treatment of memory impairment following traumatic brain injury |
WO1996015788A1 (en) * | 1994-11-23 | 1996-05-30 | G.D. Searle & Co. | Use of amino-isoxazolidone compounds for improvement of implicit memory |
CA2216648A1 (en) * | 1995-02-15 | 1996-08-22 | Bearsden Bio, Inc. | Alkylcarboxy amino acids-modulators of the kainate receptor |
US6355681B2 (en) * | 1995-12-07 | 2002-03-12 | Glytech, Inc. | Glycine substitutes and precursors for treating a psychosis |
WO1997020553A1 (en) * | 1995-12-07 | 1997-06-12 | Javitt Daniel C | Treatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonists |
US6361957B1 (en) * | 1999-08-03 | 2002-03-26 | Glytech, Inc. | Assay for D-serine transport antagonist and use for treating psychosis |
FR2742748B1 (fr) * | 1995-12-21 | 1998-01-30 | Adir | Nouveau derive de 4-imidazolidinone, son procede de preparation et les compositions pharmaceutiques qui le contiennent |
KR100396114B1 (ko) * | 1996-10-31 | 2003-11-20 | 동아제약 주식회사 | D-시클로세린의 제조방법 |
RU2219924C2 (ru) | 1998-04-14 | 2003-12-27 | Дзе Дженерал Хоспитал Корпорейшн | Способ лечения нейропсихиатрических расстройств |
ES2262322T3 (es) * | 1998-06-10 | 2006-11-16 | Meiji Seika Kaisha, Ltd. | Tratamiento de la degenaracion espinocereberal y comoposiciones utiles para el tratamiento de degeneracion espinocerebelar. |
US20040122090A1 (en) * | 2001-12-07 | 2004-06-24 | Lipton Stuart A. | Methods for treating neuropsychiatric disorders with nmda receptor antagonists |
AU2002311784B2 (en) * | 2001-03-29 | 2007-11-22 | Michael Davis | Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning |
US20060252761A1 (en) * | 2001-03-29 | 2006-11-09 | Michael Davis | Augmentation of extinction via administration of sub-antimicrobial doses of D-cycloserine |
KR20040016849A (ko) * | 2001-04-02 | 2004-02-25 | 파노라마 리서치, 인크. | 치료제로 사용되는 항산화제 니트로옥사이드 및 니트론류 |
US7160913B2 (en) * | 2002-09-13 | 2007-01-09 | Thomas Jefferson University | Methods and kit for treating Parkinson's disease |
MXPA05012493A (es) * | 2003-05-27 | 2006-05-25 | Forest Laboratories | Combinacion de un antagonista del receptor de nmda y un inhibidor selectivo de reabsorcion de serotonina para el tratamiento de depresion y otros trastornos de estado de animo. |
EP1660634A4 (en) * | 2003-08-08 | 2009-02-18 | Burnham Inst | P16-mediated regulation of NMDA receptors |
US7619007B2 (en) | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
CA2604052C (en) * | 2005-04-06 | 2014-07-08 | Adamas Pharmaceuticals, Inc. | Methods and compositions for the treatment of cns-related conditions |
KR101769999B1 (ko) | 2008-09-18 | 2017-08-21 | 노오쓰웨스턴 유니버시티 | Nmda 수용체 조절제 및 그의 용도 |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
US8951968B2 (en) | 2009-10-05 | 2015-02-10 | Northwestern University | Methods of treating depression and other related diseases |
SG10201811584RA (en) | 2010-02-11 | 2019-01-30 | Univ Northwestern | Secondary Structure Stabilized NMDA Receptor Modulators And Uses Thereof |
KR101692275B1 (ko) | 2010-02-11 | 2017-01-04 | 노오쓰웨스턴 유니버시티 | 2차 구조 안정화된 nmda 수용체 조절제 및 그의 용도 |
DK2951183T3 (da) | 2013-01-29 | 2019-06-03 | Aptinyx Inc | Spiro-lactam-nmda-receptormodulatorer og anvendelser heraf |
BR112015018094A2 (pt) | 2013-01-29 | 2017-07-18 | Naurex Inc | moduladores de receptor nmda de espiro-lactama e usos dos mesmos |
BR112015018092A2 (pt) | 2013-01-29 | 2017-07-18 | Naurex Inc | moduladores de receptor de nmda de espiro-lactama e usos dos mesmos |
EA032153B1 (ru) | 2013-01-29 | 2019-04-30 | Аптиникс Инк. | Спиролактамные модуляторы nmda-рецептора и их применение |
CA2899010A1 (en) | 2013-01-29 | 2014-08-07 | Naurex, Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
WO2017201285A1 (en) | 2016-05-19 | 2017-11-23 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
MX2018014202A (es) | 2016-05-19 | 2019-06-20 | Aptinyx Inc | Moduladores del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos. |
PE20190504A1 (es) | 2016-08-01 | 2019-04-10 | Aptinyx Inc | Moduladores del receptor nmda espiro-lactam y uso de los mismos |
CN109843889B (zh) | 2016-08-01 | 2022-03-15 | 阿普廷伊克斯股份有限公司 | 螺-内酰胺nmda调节剂和使用其的方法 |
AU2017306136B2 (en) | 2016-08-01 | 2021-10-21 | Aptinyx Inc. | Spiro-lactam NMDA receptor modulators and uses thereof |
CN109937204B (zh) | 2016-08-01 | 2022-11-25 | 阿普廷伊克斯股份有限公司 | 螺-内酰胺nmda受体调节剂及其用途 |
PE20190502A1 (es) | 2016-08-01 | 2019-04-10 | Aptinyx Inc | Moduladores del receptor nmda spiro-lactam y bis-spiro-lactam y uso de los mismos |
EP3427729A1 (en) | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid for use in treating epileptic diseases, disorders or conditions |
AU2019215058A1 (en) | 2018-01-31 | 2020-09-17 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
US12012413B2 (en) | 2019-11-11 | 2024-06-18 | Tenacia Biotechnology (Hong Kong) Co., Limited | Methods of treating painful diabetic peripheral neuropathy |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3050800C2 (pt) * | 1979-03-22 | 1989-06-22 | Continental Pharma Inc., Bruessel/Bruxelles, Be |
-
1987
- 1987-12-01 US US07/127,121 patent/US4904681A/en not_active Expired - Lifetime
-
1988
- 1988-11-28 PH PH37866A patent/PH26467A/en unknown
- 1988-11-29 NZ NZ227131A patent/NZ227131A/xx unknown
- 1988-11-29 EP EP88119863A patent/EP0319824B1/en not_active Expired - Lifetime
- 1988-11-29 ES ES88119863T patent/ES2040314T3/es not_active Expired - Lifetime
- 1988-11-29 IL IL88531A patent/IL88531A/xx not_active IP Right Cessation
- 1988-11-29 AT AT88119863T patent/ATE68698T1/de not_active IP Right Cessation
- 1988-11-29 IE IE356788A patent/IE61825B1/en not_active IP Right Cessation
- 1988-11-29 PT PT89109A patent/PT89109B/pt not_active IP Right Cessation
- 1988-11-29 AU AU26319/88A patent/AU622630B2/en not_active Ceased
- 1988-11-29 DE DE88119863T patent/DE3865817D1/de not_active Expired - Fee Related
- 1988-11-30 ZA ZA888981A patent/ZA888981B/xx unknown
- 1988-11-30 NO NO885337A patent/NO885337D0/no unknown
- 1988-11-30 KR KR1019880015895A patent/KR0134198B1/ko not_active IP Right Cessation
- 1988-11-30 FI FI885559A patent/FI885559A0/fi not_active Application Discontinuation
- 1988-11-30 CA CA000584621A patent/CA1328617C/en not_active Expired - Fee Related
- 1988-11-30 JP JP63303873A patent/JPH0621065B2/ja not_active Expired - Lifetime
- 1988-11-30 DK DK198806690A patent/DK173589B1/da not_active IP Right Cessation
- 1988-12-01 WO PCT/US1988/004244 patent/WO1989005144A1/en not_active Application Discontinuation
- 1988-12-01 AU AU28130/89A patent/AU2813089A/en not_active Abandoned
- 1988-12-01 EP EP89900543A patent/EP0421997A1/en not_active Withdrawn
-
1992
- 1992-01-15 GR GR910401170T patent/GR3003571T3/el unknown
- 1992-02-10 AU AU10839/92A patent/AU1083992A/en not_active Abandoned
- 1992-07-03 JP JP4177094A patent/JPH05201859A/ja active Pending
-
1994
- 1994-10-26 AU AU77467/94A patent/AU7746794A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IE61825B1 (en) | 1994-11-30 |
US4904681A (en) | 1990-02-27 |
DK669088A (da) | 1989-06-02 |
EP0319824B1 (en) | 1991-10-23 |
IL88531A (en) | 1993-02-21 |
CA1328617C (en) | 1994-04-19 |
AU622630B2 (en) | 1992-04-16 |
ES2040314T3 (es) | 1995-04-01 |
FI885559A0 (fi) | 1988-11-30 |
KR890009392A (ko) | 1989-08-01 |
IL88531A0 (en) | 1989-06-30 |
EP0421997A1 (en) | 1991-04-17 |
JPH05201859A (ja) | 1993-08-10 |
ZA888981B (en) | 1990-01-31 |
EP0319824A1 (en) | 1989-06-14 |
ATE68698T1 (de) | 1991-11-15 |
NZ227131A (en) | 1991-09-25 |
JPH0621065B2 (ja) | 1994-03-23 |
PH26467A (en) | 1992-07-27 |
KR0134198B1 (ko) | 1998-04-21 |
PT89109B (pt) | 1993-07-30 |
IE883567L (en) | 1989-06-01 |
NO885337D0 (no) | 1988-11-30 |
DK173589B1 (da) | 2001-04-02 |
AU2813089A (en) | 1989-07-05 |
AU1083992A (en) | 1992-05-07 |
JPH01193220A (ja) | 1989-08-03 |
DK669088D0 (da) | 1988-11-30 |
WO1989005144A1 (en) | 1989-06-15 |
GR3003571T3 (pt) | 1993-03-16 |
AU2631988A (en) | 1989-06-01 |
DE3865817D1 (pt) | 1991-11-28 |
AU7746794A (en) | 1995-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT89109A (pt) | Metodo para melhorar a funcao cognitiva por administracao de d-ciclosserina e suas pro-drogas | |
DE3779053D1 (pt) | ||
PT81125B (pt) | Processo para a preparacao de compostos macrolidos por fermentacao de organismos streptomyces | |
ES2093636T3 (es) | Uso de un compuesto de 15-ceto-prostaglandina para la mejora de la funcion encefalica. | |
ZA911502B (en) | A pharmaceutical solution | |
PT94210A (pt) | Processo para a preparacao de novos derivados piranilicos de cianoguanidina com accao estimulante dos canais de potassio | |
BR9004493A (pt) | Processo para a preparacao de um composto de 23-(alquil-c1-4-oxima)-ll-f28249 | |
ES2085898T3 (es) | Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina. | |
ES495354A0 (es) | Un procedimiento para la preparacion de un compuesto de 1,1-dioxido de penam | |
AU7591187A (en) | Novel fungicidal compositions | |
ES548385A0 (es) | Un procedimiento para la produccion estereoespecifia de un compuesto de b-lactama. | |
PT92270A (pt) | Processo para a preparacao de solvatos de um antibiotico beta-lactamico | |
ES529736A0 (es) | Un procedimiento para la preparacion de 3-formil-2-nitrometilen-tetrahidro-2h-1, 3-tiazina | |
ES524455A0 (es) | Un procedimiento para la produccion de un n-fenilcarbamato. | |
ES547777A0 (es) | Un procedimiento para la produccion de elastomeros de poliu-retano-urea | |
ES551678A0 (es) | Un procedimiento para la preparacion de un nuevo compuesto denominado sustancia n. 51262 por cultivo de un microorganismo del genero streptomyces | |
ES2089176T3 (es) | Procedimiento para la preparacion de carboditioatos de piperidina fluorometil-sustituidos. | |
RO91594A (ro) | Compozitie erbicida solida | |
PT96088A (pt) | Processo para a preparacao de compostos moluscicidas 2,4,5-tribomopirrole-3-carbonitrilo | |
ATE177104T1 (de) | Cephalosporinderivative | |
IT8019611A0 (it) | Procedimento per la stabilizzazione di un composto alogenante. | |
ES495036A0 (es) | Un procedimiento para la produccion de analogos de cefalosporina. | |
DK36689D0 (da) | Fremgangsmaade til fremstilling af et 16-methoxy-16-methyl-prostaglandin e1-derivat, samt ved fremgangsmaaden anvendelige mellemprodukter | |
ES545213A0 (es) | Un procedimiento para la fabricacion de penicilina g. | |
ES527024A0 (es) | Un procedimiento para sintetizar compuestos analogos de 13,14-dideshidro-15-oxo-prostaglandina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG3A | Patent granted, date of granting |
Effective date: 19930106 |
|
MM3A | Annulment or lapse |
Effective date: 20060706 |